Seeing Is Believing
Healthcare - Sector
ARWR is currently covered by 12 analysts with an average price target of $90.52. This is a potential upside of $30.62 (51.12%) from yesterday's end of day stock price of $59.9.
Arrowhead Pharmaceuticals's activity chart (see below) currently has 297 price targets and 280 ratings on display. The stock rating distribution of ARWR is 25.58% HOLD and 74.42% BUY.
Analysts average stock forecasts to be materialized ratio is 80.75% with an average time for these price targets to be met of 382.34 days.
Highest price target for ARWR is $126, Lowest price target is $35, average price target is $90.52.
Most recent stock forecast was given by MICHAEL YEE from UBS on 15-Oct-2026. First documented stock forecast 07-Feb-2014.
Currently out of the existing stock ratings of ARWR, 11 are a HOLD (25.58%), 32 are a BUY (74.42%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Mar-2014
$109
$49.1 (81.97%)
$9
16 days ago
(15-Oct-2026)
2/3 (66.67%)
$50.5 (86.32%)
1073
Buy Since 16-Sep-2020
$115
$55.1 (91.99%)
$115
16 days ago
(15-Oct-2026)
23/29 (79.31%)
$56.5 (96.58%)
528
Hold Since 05-Jun-2024
$74
$14.1 (23.54%)
$85
1 months 7 days ago
(24-Sep-2026)
6/7 (85.71%)
$7.93 (12.00%)
283
Buy Since 05-Feb-2021
$120
$60.1 (100.33%)
$120
1 months 30 days ago
(01-Sep-2026)
13/35 (37.14%)
$37.26 (45.03%)
423
Buy Since 12-May-2020
$100
$40.1 (66.94%)
$87
2 months ago
(31-Aug-2026)
20/21 (95.24%)
$17.61 (21.37%)
590
What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on ARWR (Arrowhead Pharmaceuticals)?
Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?